BTAI

BioXcel Therapeutics, Inc.

Contracts

Total Value

Stock Metrics

16.0%

Short % Float

9.7d to cover · Moderate squeeze

26.0%

Inst % Float

10 holders · 2026-06-30

Millennium Managem

Top Holder

6.8% of float

26.4M sh

Public Float

65/100

Dilution Score

High

2 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

65/100

HIGH

Inst: 25.99% · Top: Millennium Management Llc

Biotech Analytics

Neuroscience

41.42

Dilution Risk: HIGHScore drop -7ptsSqueeze risk: MODERATEBiotech Grade: D

Insider Buying0

Publications100

Dilution Risk65

Clinical Trials38

Short Interest50